Below are the most recent publications written about "Liver" by people in Profiles.
-
Xing R, Xu M, Reil D, Destefano A, Cui M, Liu N, Liang J, Xu G, Luo L, Xu M, Zhang F, Tai PWL, Wei Y, Gruntman AM, Flotte TR, Gao G, Wang D. A single amino acid variant in the variable region I of AAV capsid confers liver detargeting. PLoS Pathog. 2025 Sep; 21(9):e1013533.
-
Matsuoka Y, Katsumata Y, Chu PS, Morikawa R, Nakamoto N, Iguchi K, Takahashi K, Kou T, Ito R, Taura K, Yazumi S, Terajima H, Honjo G, Ichihara G, Muramoto Y, Sato K, Maeda R, Hata K, Toriu N, Yanagita M, Tajima M, Fagarasan S, Yamada KI, Sugiura Y. Monitoring ferroptosis in vivo: Iron-driven volatile oxidized lipids as breath biomarkers. Redox Biol. 2025 Oct; 86:103858.
-
Ekuban FA, Gripshover TC, Ames P, Biswas K, Bolatimi OE, Abramson J, Iyer M, Luo J, Ekuban A, Hwang JY, Park JW, Banerjee M, Watson WH, Wahlang B, Bello D, Schlezinger JJ, McClain CJ, Cave MC. Perfluorooctane sulfonate exposure and alcohol-associated liver disease severity in a mouse chronic-binge ethanol feeding model. Toxicol Sci. 2025 Aug 01; 206(2):388-408.
-
Jantarat T, Doungchawee J, Zhang X, Rotello VM, Vachet RW. Image Fusion for Improving the Spatial Resolution of LA-ICP-MS Imaging. Anal Chem. 2025 Jul 15; 97(27):14557-14564.
-
Fern?ndez-Gonz?lez I, Freire-Agulleiro O, Ferreira V, Silveira-Loureiro M, Rial-Pensado E, Garrido-Gil P, Mart?nez G, Rada P, Labandeira-Garc?a JL, Mittag J, Gonz?lez-Garc?a I, Di?guez C, Nogueiras R, Valverde ?M, Davis RJ, Sabio G, Barca-Mayo O, L?pez M. JNK1 in SF1 neurons regulates the central action of thyroid hormones on hepatic lipid metabolism. Mol Metab. 2025 Aug; 98:102170.
-
Pinto-Hernandez P, Fernandez-Sanjurjo M, Paget D, Caravia XM, Roiz-Valle D, Castilla-Silgado J, Diez-Robles S, Coto-Vilcapoma A, Fernandez-Vivero D, Gama-Perez P, Garcia-Roves PM, Lopez-Otin C, Zierath JR, Krook A, Fernandez-Garcia B, Tomas-Zapico C, Iglesias-Gutierrez E. Training-induced plasma miR-29a-3p is secreted by skeletal muscle and contributes to metabolic adaptations to resistance exercise in mice. Mol Metab. 2025 Aug; 98:102173.
-
Colletta A, Cooper KM, Placentino G, Devuni D, Colletta C. Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic liver disease and type 2 diabetes. Front Endocrinol (Lausanne). 2025; 16:1531295.
-
Dagdeviren S, Hoang MF, Wang J, Goldberger T, Yu AM, Blair SJ, Benoit JC, Ricci-Blair EM, Melnik VY, Kim BY, Tauer LA, Scholz JJ, Worthmann A, Schlein C, Stone D, Deuitch NT, Aksentijevich I, Schnappauf O, Whited JL, Kim JK, Lee RT. Covalent binding of thioredoxin to TXNIP is required for diet-induced insulin resistance in the liver. J Biol Chem. 2025 Jun; 301(6):110214.
-
Ravi S, Sharma T, Yip M, Yang H, Xie J, Gao G, Tai PWL. A deep learning model trained on expressed transcripts across different tissue types reveals cell-type codon-optimization preferences. Nucleic Acids Res. 2025 Mar 20; 53(6).
-
Schlezinger JJ, Bello A, Mangano KM, Biswas K, Patel PP, Pennoyer EH, Wolever TMS, Heiger-Bernays WJ, Bello D. Per- and poly-fluoroalkyl substances (PFAS) in circulation in a Canadian population: their association with serum-liver enzyme biomarkers and piloting a novel method to reduce serum-PFAS. Environ Health. 2025 Mar 15; 24(1):10.